The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07367880

Acronym

TeDIMO

Enrollment

220

Registered

2026-01-26

Start date

2026-02-23

Completion date

2032-02-01

Last updated

2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer s Disease

Keywords

unique entities, denomination, identification, landmarks

Brief summary

The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.

Interventions

OTHERIdentification and naming task

Task of identification and naming of landmarks and celebrities

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to 95 Years

Healthy volunteers

Yes

Inclusion criteria

: * Alzheimer's disease: * Age ≥ 50 years and older * Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011. * Score 18≤ MMSE ≤26 * Controls: * Age ≥ 50 years and older * MMSE score ≥ 26 For all subjects * No objection from the participant

Exclusion criteria

* Alzheimer's disease: * Persons referred to in Articles L1121-5 to L1121-8 of the CSP * Controls: * Memory complaints * Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects * Significant neurological or psychiatric history * Taking psychotropic medication (neuroleptics) * Poor command of the French language, comprehension difficulties * Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.) * Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)

Design outcomes

Primary

Measure	Time frame	Description
Difference between the two groups in the identification and naming task involving famous landmarks	1 month	show a significant difference in performance between the two groups in the identification and naming task involving famous landmarks

Secondary

Measure	Time frame
Development and standardization of a new tool for screening for naming disorders and visual identification of unique entities.	5 years

Countries

France

Contacts

CONTACTSabrina Iannuzzi, Neuropsychologist

siannuzzi@chu-grenoble.fr+334.76.76.57.90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026